Chinese companies have over the past five years obtained exclusive distribution rights in Taiwan for 29 percent of new pharmaceuticals, the Legislative Yuan said, urging the government to intervene, as it said the issue extends far beyond Chinese agency over the Pfizer-BioNTech COVID-19 vaccine.
Right of agency for drug distribution has received widespread attention this year, after Germany’s BioNTech inked a deal with Shanghai Fosun Pharmaceutical Group (上海復星醫藥集團) to develop and distribute its COVID-19 vaccine in Taiwan, China, Hong Kong and Macau.
This has complicated Taipei’s efforts to procure the vaccine.
Private entities have stepped in to purchase doses to donate to the government, including Taiwan Semiconductor Manufacturing Co (台積電), the Buddhist Compassion Relief Tzu Chi Foundation and the Hon Hai Precision Industry Co (鴻海精密)-affiliated Yonglin Foundation.
In a report dated Monday, the Legislative Yuan’s Judiciary and Organic Laws and Statutes Bureau decried the arrangement as unreasonable.
“Requiring South Korea to purchase vaccines through a North Korean distributor or Israel to go through a Palestinian firm would be preposterous,” the report said.
Granting exclusive distribution rights in a nation to its political and military adversary is ethically problematic, it said.
Due to the antagonism and mutual distrust between the two nations, it is highly unlikely that they would complete a contract and instead use it as a tool for political manipulation, it added.
This would further hinder transactions and jeopardize the right to healthcare of the “represented country,” the report added.
Right of agency over pharmaceuticals has long been an issue, the bureau said.
Over the past five years, Chinese firms have obtained exclusive distribution rights to Taiwan for 29 percent of new pharmaceuticals, posing an increasingly serious problem that cannot be ignored, it said.
The bureau recommended that the Ministry of Foreign Affairs and national security agencies intervene in China’s attempts to monopolize Taiwan’s pharmaceutical market.
Using appropriate channels, officials should persuade multinationals to avoid signing right-of-agency contracts for Taiwan with Chinese distributors, thereby preventing human rights, moral and political controversies, it said.
All import licensing procedures should follow WTO protocols, as Taiwan, Germany and China are all members of the global trade body, the report added, recommending that the Ministry of Economic Affairs seek a decision from the WTO or another international economic forum to ensure fair and timely access to vaccines worldwide.
PROVOCATIVE: Chinese Deputy Ambassador to the UN Sun Lei accused Japan of sending military vessels to deliberately provoke tensions in the Taiwan Strait China denounced remarks by Japan and the EU about the South China Sea at a UN Security Council meeting on Monday, and accused Tokyo of provocative behavior in the Taiwan Strait and planning military expansion. Ayano Kunimitsu, a Japanese vice foreign minister, told the Council meeting on maritime security that Tokyo was seriously concerned about the situation in the East China and South China seas, and reiterated Japan’s opposition to any attempt to change the “status quo” by force, and obstruction of freedom of navigation and overflight. Stavros Lambrinidis, head of the EU delegation to the UN, also highlighted South China Sea
SILENCING CRITICS: In addition to blocking Taiwan, China aimed to prevent rights activists from speaking out against authoritarian states, a Cabinet department said The Ministry of Foreign Affairs (MOFA) yesterday condemned transnational repression by Beijing after RightsCon, a major digital human rights conference scheduled to be held in Zambia this week, was abruptly canceled due to Chinese pressure over Taiwanese participation. This year’s RightsCon, the world’s largest conference discussing issues “at the intersection of human rights and technology,” was scheduled to take place from tomorrow to Friday in Lusaka, and expected to draw 2,600 in-person attendees from 150 countries, along with 1,100 online participants. However, organizers were forced to cancel the event due to behind-the-scenes pressure from China, the ministry said, expressing its “strongest condemnation”
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, said it expects its 2-nanometer (2nm) chip capacity to grow at a compound annual rate of 70 percent from this year to 2028. The projection comes as five fabs begin volume production of 2-nanometer chips this year — two in Hsinchu and three in Kaohsiung — TSMC senior vice president and deputy cochief operating officer Cliff Hou (侯永清) said at the company’s annual technology symposium in Silicon Valley, California, last week. Output in the first year of 2-nanometer production, which began in the fourth quarter of last year, is expected to
Taiwan’s economy grew far faster than expected in the first quarter, as booming demand for artificial intelligence (AI) applications drove a surge in exports, spilling over into investment and consumption, the Directorate-General of Budget, Accounting and Statistics (DGBAS) said yesterday. GDP growth was 13.69 percent year-on-year during the January-to-March period, beating the DGBAS’ February forecast by 2.23 percentage points and marking the most robust growth in nearly four decades, DGBAS senior official Chiang Hsin-yi (江心怡) told a news conference in Taipei. The result was powered by exports, which remain the backbone of Taiwan’s economy, Chiang said. Outbound shipments jumped 51.12 percent year-on-year to
RSS